Pharvaris N.V.

NASDAQ:PHVS

Biotechnology

Healthcare
$31.55 -1.93%

-$0.64 today

Market cap
$2.21B
Beta
-2.33
P/E (TTM)
-11.0
EPS (TTM)
-$2.59
52W Low $16.72High $34.41

Volume 0.39M

Average 0.31M

PHVS Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How PHVS compares with its peers on the latest reported figures

PHVS Competitors Peer median
Net Margin for PHVS and competitors
Company Period LTM level YoY 3-year change
PHARPharming Group N.V.LTM Mar 20263.3% +7.7 pp-5.9 pp
BMRNBioMarin Pharmaceutical Inc.LTM Sep 2026-11.9% -28.8 pp+4.1 pp
TVTXTravere Therapeutics, Inc.LTM Sep 2026-18.7% +1.7 pp+249.2 pp
BCRXBioCryst Pharmaceuticals, Inc.LTM Jun 2026-40.9% -34.5 pp+121.4 pp
RLYBRallybio CorporationLTM Mar 2026-911.1% +4771.1 pp—
PHVSPharvaris N.V.FY2025— ——
VERAVera Therapeutics, Inc.FY2025— ——
Peer median (excluding PHVS) -18.7%+1.7 pp+62.7 pp

Competitors are the stored peer set for PHVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development35.79M57.38M65.58M98.56M124.48M
Selling, General & Admin18.35M29.34M31.34M47.12M45.34M
Operating Expenses54.14M86.71M96.91M145.69M169.82M
Depreciation & Amortization77.37K152.94K257.55K269.56K418.35K
EBITDA(42.31M)(86.56M)(99.57M)(145.42M)(173.29M)
EBITDA Margin—————
Operating Income(54.14M)(86.71M)(96.91M)(145.69M)(169.82M)
Operating Margin—————
Interest Income2681605.47M0
Interest Expense278.18K16.11K000
Other Income / Expenses11.48M11.06M(2.91M)13.29M(3.89M)
Income Before Tax(42.66M)(75.65M)(99.83M)(132.4M)(173.71M)
Pre-Tax Margin—————
Income Tax Expense70.12K679.09K1.05M1.83M1.99M
Net Income(42.73M)(76.33M)(100.88M)(134.22M)(175.7M)
Net Margin—————
EPS (Basic)(1.41)(2.27)(2.63)(2.48)(2.97)
EPS (Diluted)(1.41)(2.27)(2.63)(2.48)(2.97)
Weighted Avg Shares30.41M33.59M38.39M54.02M59.16M
Weighted Avg Shares (Diluted)30.41M33.59M38.39M54.02M59.16M

Pharvaris N.V.

NASDAQ:PHVS

Intrinsic Alpha fair value

Locked

Current Price

$31.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.